vs
Side-by-side financial comparison of Bank First Corp (BFC) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $44.9M, roughly 1.1× Bank First Corp). Bank First Corp runs the higher net margin — 45.8% vs -4.8%, a 50.6% gap on every dollar of revenue. On growth, Bank First Corp posted the faster year-over-year revenue change (12.1% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $51.0M). Over the past eight quarters, Bank First Corp's revenue compounded faster (9.1% CAGR vs -20.2%).
First Horizon Corporation, formerly First Tennessee Bank, is a financial services company, founded in 1864, and based in Memphis, Tennessee. Through its banking subsidiary First Horizon Bank, it provides financial services through locations in 12 states across the Southeast, a region in which it is the fourth largest regional bank.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
BFC vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $47.7M |
| Net Profit | $18.4M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 51.0% | 14.3% |
| Net Margin | 45.8% | -4.8% |
| Revenue YoY | 12.1% | -47.3% |
| Net Profit YoY | 4.8% | -200.9% |
| EPS (diluted) | $1.87 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $47.7M | ||
| Q3 25 | $44.2M | $122.1M | ||
| Q2 25 | $41.6M | $85.2M | ||
| Q1 25 | $43.1M | $41.1M | ||
| Q4 24 | $40.1M | $90.5M | ||
| Q3 24 | $40.8M | $91.6M | ||
| Q2 24 | $38.9M | $94.4M | ||
| Q1 24 | $37.7M | $74.9M |
| Q4 25 | $18.4M | $-2.3M | ||
| Q3 25 | $18.0M | $40.1M | ||
| Q2 25 | $16.9M | $23.6M | ||
| Q1 25 | $18.2M | $-37.4M | ||
| Q4 24 | $17.5M | $2.3M | ||
| Q3 24 | $16.6M | $3.6M | ||
| Q2 24 | $16.1M | $-860.0K | ||
| Q1 24 | $15.4M | $-4.2M |
| Q4 25 | 51.0% | 14.3% | ||
| Q3 25 | 50.8% | 61.8% | ||
| Q2 25 | 49.7% | 53.2% | ||
| Q1 25 | 51.3% | -70.7% | ||
| Q4 24 | 54.4% | 34.8% | ||
| Q3 24 | 50.7% | 28.0% | ||
| Q2 24 | 51.0% | 26.5% | ||
| Q1 24 | 45.6% | 14.7% |
| Q4 25 | 45.8% | -4.8% | ||
| Q3 25 | 40.7% | 32.8% | ||
| Q2 25 | 40.5% | 27.7% | ||
| Q1 25 | 42.3% | -90.9% | ||
| Q4 24 | 49.3% | 2.5% | ||
| Q3 24 | 40.6% | 4.0% | ||
| Q2 24 | 41.3% | -0.9% | ||
| Q1 24 | 40.8% | -5.6% |
| Q4 25 | $1.87 | $0.01 | ||
| Q3 25 | $1.83 | $0.23 | ||
| Q2 25 | $1.71 | $0.14 | ||
| Q1 25 | $1.82 | $-0.23 | ||
| Q4 24 | $1.75 | $0.03 | ||
| Q3 24 | $1.65 | $0.02 | ||
| Q2 24 | $1.59 | $-0.01 | ||
| Q1 24 | $1.51 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $243.2M | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $643.8M | $-261.8M |
| Total Assets | $4.5B | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $243.2M | $215.5M | ||
| Q3 25 | $126.2M | $140.4M | ||
| Q2 25 | $120.3M | $92.9M | ||
| Q1 25 | $300.9M | $108.5M | ||
| Q4 24 | $261.3M | $88.6M | ||
| Q3 24 | $204.4M | $88.2M | ||
| Q2 24 | $99.0M | $105.5M | ||
| Q1 24 | $83.4M | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $643.8M | $-261.8M | ||
| Q3 25 | $628.1M | $-264.2M | ||
| Q2 25 | $612.3M | $-308.2M | ||
| Q1 25 | $648.4M | $-334.1M | ||
| Q4 24 | $639.7M | $-301.3M | ||
| Q3 24 | $628.9M | $-311.3M | ||
| Q2 24 | $614.6M | $-321.7M | ||
| Q1 24 | $609.3M | $-330.5M |
| Q4 25 | $4.5B | $396.9M | ||
| Q3 25 | $4.4B | $396.1M | ||
| Q2 25 | $4.4B | $342.9M | ||
| Q1 25 | $4.5B | $327.2M | ||
| Q4 24 | $4.5B | $350.9M | ||
| Q3 24 | $4.3B | $389.5M | ||
| Q2 24 | $4.1B | $395.6M | ||
| Q1 24 | $4.1B | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $62.5M | $74.6M |
| Free Cash FlowOCF − Capex | $51.0M | $74.6M |
| FCF MarginFCF / Revenue | 113.6% | 156.3% |
| Capex IntensityCapex / Revenue | 25.5% | 0.0% |
| Cash ConversionOCF / Net Profit | 3.40× | — |
| TTM Free Cash FlowTrailing 4 quarters | $75.8M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $62.5M | $74.6M | ||
| Q3 25 | $15.5M | $47.6M | ||
| Q2 25 | $11.9M | $-15.1M | ||
| Q1 25 | $6.2M | $20.0M | ||
| Q4 24 | $65.8M | $15.2M | ||
| Q3 24 | $18.8M | $9.9M | ||
| Q2 24 | $14.9M | $33.5M | ||
| Q1 24 | $1.3M | $45.0M |
| Q4 25 | $51.0M | $74.6M | ||
| Q3 25 | $12.5M | $47.6M | ||
| Q2 25 | $8.2M | $-15.1M | ||
| Q1 25 | $4.0M | $19.9M | ||
| Q4 24 | $58.6M | — | ||
| Q3 24 | $16.9M | $9.9M | ||
| Q2 24 | $13.7M | $33.4M | ||
| Q1 24 | $551.0K | $44.9M |
| Q4 25 | 113.6% | 156.3% | ||
| Q3 25 | 28.2% | 39.0% | ||
| Q2 25 | 19.8% | -17.7% | ||
| Q1 25 | 9.3% | 48.4% | ||
| Q4 24 | 146.3% | — | ||
| Q3 24 | 41.5% | 10.8% | ||
| Q2 24 | 35.3% | 35.4% | ||
| Q1 24 | 1.5% | 60.0% |
| Q4 25 | 25.5% | 0.0% | ||
| Q3 25 | 6.7% | 0.0% | ||
| Q2 25 | 8.7% | 0.0% | ||
| Q1 25 | 5.0% | 0.1% | ||
| Q4 24 | 18.0% | 0.0% | ||
| Q3 24 | 4.5% | 0.0% | ||
| Q2 24 | 3.1% | 0.1% | ||
| Q1 24 | 2.1% | 0.1% |
| Q4 25 | 3.40× | — | ||
| Q3 25 | 0.86× | 1.19× | ||
| Q2 25 | 0.70× | -0.64× | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 3.75× | 6.74× | ||
| Q3 24 | 1.13× | 2.71× | ||
| Q2 24 | 0.93× | — | ||
| Q1 24 | 0.09× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
